EGFR and urinary bladder cancer: We also observed that concurrent autophagy inhibition significantly enhanced the anti-clonal proliferation effects of EGFR inhibitors in T24 and J82 bladder cancer cells (Figure 3B and Figure S2Ab, respectively).